Education
About Us
Working with TipRanks
Follow Us
ThermoGenesis Holdings (THMO)
OTHER OTC:THMO
THMO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.88
Previous CloseN/A
Volume361.00
Average Volume (3M)10.93K
Market Cap
$1.58K
Enterprise ValueN/A
Total Cash (Recent Filing)$1.18M
Total Debt (Recent Filing)$7.57M
Price to Earnings (P/E)―
Beta40.80
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.75
Shares Outstanding15,847,517
10 Day Avg. Volume3,185
30 Day Avg. Volume10,933
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)<0.01
Price to Sales (P/S)0.00
P/FCF Ratio>-0.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ThermoGenesis Holdings News
PremiumCompany Announcements
ThermoGenesis Board Shake-Up Amid Governance Concerns
PremiumCompany Announcements
Haihong Zhu Steps Down as ThermoGenesis Board Director
PremiumPre-Earnings
Is THMO a Buy, Before Earnings?Options Prices
Currently, No data available
---
Ownership Overview
77.84% Insiders
0.17% Other Institutional Investors
22.00% Public Companies and
Individual Investors
THMO FAQ
What was ThermoGenesis Holdings’s price range in the past 12 months?
ThermoGenesis Holdings lowest stock price was $0.01 and its highest was $0.88 in the past 12 months.
What is ThermoGenesis Holdings’s market cap?
ThermoGenesis Holdings’s market cap is $1.58K.
When is ThermoGenesis Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ThermoGenesis Holdings’s earnings last quarter?
Currently, no data Available
Is ThermoGenesis Holdings overvalued?
According to Wall Street analysts ThermoGenesis Holdings’s price is currently Overvalued.
Does ThermoGenesis Holdings pay dividends?
ThermoGenesis Holdings does not currently pay dividends.
What is ThermoGenesis Holdings’s EPS estimate?
ThermoGenesis Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ThermoGenesis Holdings have?
ThermoGenesis Holdings has 15,847,517 shares outstanding.
What happened to ThermoGenesis Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ThermoGenesis Holdings?
Currently, no hedge funds are holding shares in THMO
Company Description
ThermoGenesis Holdings
ThermoGenesis Holdings (THMO) is a biotechnology company that focuses on the development, commercialization, and licensing of automated technologies for cell processing and cell-based therapies. The company operates within the life sciences sector, providing a range of products and services designed to improve the efficiency and effectiveness of cell therapy manufacturing processes. Core products include automated cell separation systems, cryopreservation solutions, and other bioprocessing technologies aimed at supporting the growth of the regenerative medicine field.